Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)-Reference-Cited by-同舟云学术

Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)

Published:2005 Issue:4 Volume:52 Page:1227-1236
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Antoni Christian E.,Kavanaugh Arthur,Kirkham Bruce,Tutuncu Zuhre,Burmester Gerd R.,Schneider Udo,Furst Daniel E.,Molitor Jerry,Keystone Edward,Gladman Dafna,Manger Bernhard,Wassenberg Siegfried,Weier Ralf,Wallace Daniel J.,Weisman Michael H.,Kalden Joachim R.,Smolen Josef

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference36 articles.

1. Mortality studies in psoriatic arthritis. Results from a single outpatient clinic. I. Causes and risk of death

2. Mortality studies in psoriatic arthritis: Results from a single outpatient center. II. Prognostic indicators for death

3. A polyarticular onset predicts erosive and deforming disease in psoriatic arthritis

4. Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: A multinational, double-blind, randomized, placebo-controlled clinical trial

Cited by 555 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment with Targeted Therapy in Patients with Psoriatic Arthritis and Inadequate Response to Methotrexate: Proposal for a Rational Strategy;Rheumatology and Therapy;2024-08-12

2. Short Term Efficacy of Biological Treatment for Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Network Meta-Analysis;2024-08-05

3. Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics: post hoc analysis of a phase 3 study;Clinical Rheumatology;2024-06-07

4. Risk of infections in psoriatic arthritis or axial spondyloarthritis patients treated with targeted therapies: A meta-analysis of randomized controlled trials;Joint Bone Spine;2024-05

5. Effectiveness and safety of biological and target synthetic drugs treatment for psoriatic arthritis: a systematic review with network meta-analysis;Advances in Rheumatology;2024-03-21